The opinion in support of the decision being entered today
is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte MAWAHEB M. EL-NAGGAR and AHMED S. MOUSA
__________
Appeal 2007-2834
Application 09/943,048
Technology Center 1600
__________
Decided: September 20, 2007
__________
Before ERIC GRIMES, LORA M. GREEN, and RICHARD M.
LEBOVITZ, Administrative Patent Judges.
GRIMES, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 involving claims to a
composition and method for treating inflammatory disorders. The Examiner
has rejected the claims as obvious. We have jurisdiction under 35 U.S.C.
§ 6(b). We reverse.
BACKGROUND
“One of the most adverse effects of nonsteroidal anti-inflammatory
drugs (NSAIDs) is their ulcerogenic activity on the gastrointestinal tract”
Page: 1 2 3 4 5 6 7 8 9 Next
Last modified: September 9, 2013